Inotek Pharma (ITEK) Reports Q1 Loss of $0.38

Inotek Pharma (NASDAQ: ITEK) reported Q1 EPS of ($0.38), versus ($0.21) reported last year.

For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue